324 related articles for article (PubMed ID: 22278155)
1. Prognostic significance of transforming growth factor beta (TGF-β) signaling axis molecules and E-cadherin in colorectal cancer.
Lampropoulos P; Zizi-Sermpetzoglou A; Rizos S; Kostakis A; Nikiteas N; Papavassiliou AG
Tumour Biol; 2012 Aug; 33(4):1005-14. PubMed ID: 22278155
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers of TGF-β signaling pathway and prognosis of pancreatic cancer.
Javle M; Li Y; Tan D; Dong X; Chang P; Kar S; Li D
PLoS One; 2014; 9(1):e85942. PubMed ID: 24465802
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
[TBL] [Abstract][Full Text] [Related]
4. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
5. Antimetastatic role of Smad4 signaling in colorectal cancer.
Zhang B; Halder SK; Kashikar ND; Cho YJ; Datta A; Gorden DL; Datta PK
Gastroenterology; 2010 Mar; 138(3):969-80.e1-3. PubMed ID: 19909744
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
[TBL] [Abstract][Full Text] [Related]
7. Smad7 induces hepatic metastasis in colorectal cancer.
Halder SK; Rachakonda G; Deane NG; Datta PK
Br J Cancer; 2008 Sep; 99(6):957-65. PubMed ID: 18781153
[TBL] [Abstract][Full Text] [Related]
8. Low expression of transforming growth factor beta-1 in cancer tissue predicts a poor prognosis for patients with stage III rectal cancers.
Chun HK; Jung KU; Choi YL; Hong HK; Kim SH; Yun SH; Kim HC; Lee WY; Cho YB
Oncology; 2014; 86(3):159-69. PubMed ID: 24643220
[TBL] [Abstract][Full Text] [Related]
9. Role of TGF-beta1, its receptor TGFbetaRII, and Smad proteins in the progression of colorectal cancer.
Gulubova M; Manolova I; Ananiev J; Julianov A; Yovchev Y; Peeva K
Int J Colorectal Dis; 2010 May; 25(5):591-9. PubMed ID: 20165854
[TBL] [Abstract][Full Text] [Related]
10. Preliminary Study of the Role F-Box Protein 32 (FBXO32) in Colorectal Neoplasms Through the Transforming Growth Factor beta (TGF-β)/Smad4 Signalling Pathway.
Yuan X; Zhang Z; Jiang K; Wang X; Li Y
Med Sci Monit; 2018 Feb; 24():1080-1088. PubMed ID: 29465067
[TBL] [Abstract][Full Text] [Related]
11. Loss of Smad signaling in human colorectal cancer is associated with advanced disease and poor prognosis.
Xie W; Rimm DL; Lin Y; Shih WJ; Reiss M
Cancer J; 2003; 9(4):302-12. PubMed ID: 12967141
[TBL] [Abstract][Full Text] [Related]
12. Expression of TGF-beta signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics.
Figueroa JD; Flanders KC; Garcia-Closas M; Anderson WF; Yang XR; Matsuno RK; Duggan MA; Pfeiffer RM; Ooshima A; Cornelison R; Gierach GL; Brinton LA; Lissowska J; Peplonska B; Wakefield LM; Sherman ME
Breast Cancer Res Treat; 2010 Jun; 121(3):727-35. PubMed ID: 19937272
[TBL] [Abstract][Full Text] [Related]
13. Roles of VEGF-C and Smad4 in the lymphangiogenesis, lymphatic metastasis, and prognosis in colon cancer.
Li X; Liu B; Xiao J; Yuan Y; Ma J; Zhang Y
J Gastrointest Surg; 2011 Nov; 15(11):2001-10. PubMed ID: 21786062
[TBL] [Abstract][Full Text] [Related]
14. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
Fanayan S; Firth SM; Baxter RC
J Biol Chem; 2002 Mar; 277(9):7255-61. PubMed ID: 11751851
[TBL] [Abstract][Full Text] [Related]
15. Smad4 overexpression in hepatocellular carcinoma is strongly associated with transforming growth factor beta II receptor immunolabeling.
Torbenson M; Marinopoulos S; Dang DT; Choti M; Ashfaq R; Maitra A; Boitnott J; Wilentz RE
Hum Pathol; 2002 Sep; 33(9):871-6. PubMed ID: 12378510
[TBL] [Abstract][Full Text] [Related]
16. Associations of the Transforming Growth Factor β/Smad Pathway, Body Mass Index, and Physical Activity With Breast Cancer Outcomes: Results From the Shanghai Breast Cancer Study.
Su Y; Cai H; Zheng Y; Qiu Q; Lu W; Shu XO; Cai Q
Am J Epidemiol; 2016 Oct; 184(7):501-509. PubMed ID: 27651382
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-β promotes aggressiveness and invasion of clear cell renal cell carcinoma.
Sitaram RT; Mallikarjuna P; Landström M; Ljungberg B
Oncotarget; 2016 Jun; 7(24):35917-35931. PubMed ID: 27166254
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer.
Busch S; Acar A; Magnusson Y; Gregersson P; Rydén L; Landberg G
Oncogene; 2015 Jan; 34(1):27-38. PubMed ID: 24336330
[TBL] [Abstract][Full Text] [Related]
19. The prognostic role of TGF-β signaling pathway in breast cancer patients.
de Kruijf EM; Dekker TJA; Hawinkels LJAC; Putter H; Smit VTHBM; Kroep JR; Kuppen PJK; van de Velde CJH; Ten Dijke P; Tollenaar RAEM; Mesker WE
Ann Oncol; 2013 Feb; 24(2):384-390. PubMed ID: 23022998
[TBL] [Abstract][Full Text] [Related]
20. Smad4 and epithelial-mesenchymal transition proteins in colorectal carcinoma: an immunohistochemical study.
Ioannou M; Kouvaras E; Papamichali R; Samara M; Chiotoglou I; Koukoulis G
J Mol Histol; 2018 Jun; 49(3):235-244. PubMed ID: 29468299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
